Add to ORKGObjectives To set up a population pharmacokinetics (PPK) model of valproate (VPA) monotherapy in Chinese children with epilepsy to formulate an individualized dosage guideline. Methods VPA steady-state plasma concentration data from therapeutic drug monitoring(TDM) were collected retrospectively ...浙江省医学会
To evaluate the effects of CYP2C19 and CYP2C9 genotypes on the pharmacokinetic variability of valpro...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Aim: The aim of the present study is to establish a population pharmacokinetic (PPK) model of valpro...
AIM: Using sparse data of valproate (VPA) serum concentrations to build a population pharmacokinetic...
Medical Laboratory TechnologyPharmacology & PharmacyToxicologySCI(E)CPCI-S(ISTP)0MEETING ABSTRAC...
Objectives: Valproic acid (VPA) is a broad spectrum antiepileptic drug with known efficacy profile i...
Background and Objective: Valproic acid (VPA) follows a non-linear pharmacokinetic profile in terms ...
Objectives: Valproic acid (VPA) is a broad spectrum antiepileptic drug with known efficacy profile i...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
AbstractPurpose The aims of this study were to develop a population pharmacokinetic (PPK) model of l...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
To evaluate the effects of CYP2C19 and CYP2C9 genotypes on the pharmacokinetic variability of valpro...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Aim: The aim of the present study is to establish a population pharmacokinetic (PPK) model of valpro...
AIM: Using sparse data of valproate (VPA) serum concentrations to build a population pharmacokinetic...
Medical Laboratory TechnologyPharmacology & PharmacyToxicologySCI(E)CPCI-S(ISTP)0MEETING ABSTRAC...
Objectives: Valproic acid (VPA) is a broad spectrum antiepileptic drug with known efficacy profile i...
Background and Objective: Valproic acid (VPA) follows a non-linear pharmacokinetic profile in terms ...
Objectives: Valproic acid (VPA) is a broad spectrum antiepileptic drug with known efficacy profile i...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
AbstractPurpose The aims of this study were to develop a population pharmacokinetic (PPK) model of l...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
To evaluate the effects of CYP2C19 and CYP2C9 genotypes on the pharmacokinetic variability of valpro...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic ac...